Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults

PURPOSE: Tolvaptan (TLV) is indicated to treat hyponatremia due to syndrome of inappropriate diuretic hormone (SIADH) in Europe. Treatment is to be initiated at 15 mg QD but post-approval reporting indicates increasing use of 7.5 mg as the starting dose. Physicians believe 7.5 mg is effective and ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoaf, Susan E., Bricmont, Patricia, Dandurand, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Pharmacodynamics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662662/
https://www.ncbi.nlm.nih.gov/pubmed/28803333
http://dx.doi.org/10.1007/s00228-017-2302-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662662/
https://www.ncbi.nlm.nih.gov/pubmed/28803333
http://dx.doi.org/10.1007/s00228-017-2302-7

Ejemplares similares